Dbitm1(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Dbitm1(KOMP)Wtsi |
Name: |
diazepam binding inhibitor; targeted mutation 1, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4419418 |
Gene: |
Dbi Location: Chr1:120041010-120048808 bp, - strand Genetic Position: Chr1, 52.65 cM, cytoband E2
|
IMPC: |
Dbi gene page |
|
Mutant Cell Lines: |
EPD0400_1_A12, EPD0400_1_B11, EPD0400_1_C09, EPD0400_1_D10, EPD0400_1_D11, EPD0400_1_D12, EPD0400_1_E09, EPD0400_1_E10, EPD0400_1_E11, EPD0400_1_E12, EPD0400_1_F09, EPD0400_1_F10, EPD0400_1_F11, EPD0400_1_G10, EPD0400_1_G11, EPD0400_1_H11 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 3898 starting at position 120044114 and ending at position 120048012 of Chromosome 1 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
2 reference(s) |
|